cabazitaxel,177lu-psma-617
sanofi,emcure,novartis
['crpc', 'cabazitaxel']
you don't want to miss, #therap: 177lu-psma-617 (lupsma) vs cabazitaxel in mcrpc progressing after docetaxel os after median follow-up of 3 years (anzup 1603). #asco22 presentation by sun, jun 5th: 9:00 9:12 am edt 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology